|
|
|
CfPA-The Center for Professional Advancement, Online Live
March 24, 2020 at 9:00 a.m.–1:00 p.m. (ET)
Who Should Attend? This training will benefit those involved in the manufacturing, processing, testing and release of sterile and non-sterile products within various industries such as the Pharmaceutical, Biotechnology, Drug, Biologics, Medical Device, Compounding Pharmacies, Cell Therapy and In-vitro Diagnostics Product Manufacturing. It will be especially beneficial to personnel and management in: • Quality Assurance/Control • Manufacturing • Validation • Regulatory Affairs • Sterility Assurance Manager • Sterilization professional • Shipping and Receiving • Engineering • Facility and Maintenance • Analytical Chemist/ Microbiologist
Other key management and personnel that need to provide industry training in these key compliance topics will benefit from this course as well. Course Description
|
|
|
|
|
|
Organized by:
|
|
CfPA-The Center for Professional Advancement |
|
Invited Speakers:
|
|
Charity Ogunsanya, (Owner/CEO), Pharmabiodevice Consulting LLC |
Charity Ogunsanya has more than 28 years of extensive experience within the Biologics, Pharmaceuticals, Radiopharmaceuticals, Biotechnology and Medical Device Industries and has been the Microbiology, Sterility Assurance, Contamination Control, Aseptic processing, Quality Control Subject Matter Expert (SME) for multiple fortune 100 companies.
She has a Bachelor of Science degree in Microbiology from the University of Benin-Nigeria and has a Masters degree from the Advanced Academic Master’s Biotechnology Program at the Johns Hopkins University with concentration in Biotechnology/Biodefense. She is the CEO/ Owner of her consulting firm named Pharmabiodevice Consulting LLC. Her consultancy provides support to Biologics, Pharmaceuticals, Radiopharmaceuticals, Biotechnology and Medical Device Industries.
|
|
|
|
|
|
Deadline for Abstracts:
|
|
N/A
|
|
|
|
|
|
Registration:
|
|
Please click here for registration information.
|
|
E-mail:
|
|
Jmorbit@cfpa.com
|
|
|
|
|
|
|
|